Cargando…
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
Helicobacter pylori infection consists a high global burden affecting more than 50% of the world’s population. It is implicated, beyond substantiated local gastric pathologies, i.e., peptic ulcers and gastric cancer, in the pathophysiology of several neurodegenerative disorders, mainly by inducing h...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056452/ https://www.ncbi.nlm.nih.gov/pubmed/36984505 http://dx.doi.org/10.3390/medicina59030504 |
_version_ | 1785016124976398336 |
---|---|
author | Kountouras, Jannis Doulberis, Michael Papaefthymiou, Apostolis Polyzos, Stergios A. Zavos, Christos Kazakos, Evangelos Arapoglou, Stergios Kyrailidi, Foteini Mouratidou, Maria C. Boziki, Marina Vardaka, Elisabeth |
author_facet | Kountouras, Jannis Doulberis, Michael Papaefthymiou, Apostolis Polyzos, Stergios A. Zavos, Christos Kazakos, Evangelos Arapoglou, Stergios Kyrailidi, Foteini Mouratidou, Maria C. Boziki, Marina Vardaka, Elisabeth |
author_sort | Kountouras, Jannis |
collection | PubMed |
description | Helicobacter pylori infection consists a high global burden affecting more than 50% of the world’s population. It is implicated, beyond substantiated local gastric pathologies, i.e., peptic ulcers and gastric cancer, in the pathophysiology of several neurodegenerative disorders, mainly by inducing hyperhomocysteinemia-related brain cortical thinning (BCT). BCT has been advocated as a possible biomarker associated with neurodegenerative central nervous system disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and/or glaucoma, termed as “ocular Alzheimer’s disease”. According to the infection hypothesis in relation to neurodegeneration, Helicobacter pylori as non-commensal gut microbiome has been advocated as trigger and/or mediator of neurodegenerative diseases, such as the development of Alzheimer’s disease. Among others, Helicobacter pylori-related inflammatory mediators, defensins, autophagy, vitamin D, dietary factors, role of probiotics, and some pathogenetic considerations including relevant involved genes are discussed within this opinion article. In conclusion, by controlling the impact of Helicobacter pylori-related hyperhomocysteinemia on neurodegenerative disorders might offer benefits, and additional research is warranted to clarify this crucial topic currently representing a major worldwide burden. |
format | Online Article Text |
id | pubmed-10056452 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100564522023-03-30 Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration Kountouras, Jannis Doulberis, Michael Papaefthymiou, Apostolis Polyzos, Stergios A. Zavos, Christos Kazakos, Evangelos Arapoglou, Stergios Kyrailidi, Foteini Mouratidou, Maria C. Boziki, Marina Vardaka, Elisabeth Medicina (Kaunas) Opinion Helicobacter pylori infection consists a high global burden affecting more than 50% of the world’s population. It is implicated, beyond substantiated local gastric pathologies, i.e., peptic ulcers and gastric cancer, in the pathophysiology of several neurodegenerative disorders, mainly by inducing hyperhomocysteinemia-related brain cortical thinning (BCT). BCT has been advocated as a possible biomarker associated with neurodegenerative central nervous system disorders such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and/or glaucoma, termed as “ocular Alzheimer’s disease”. According to the infection hypothesis in relation to neurodegeneration, Helicobacter pylori as non-commensal gut microbiome has been advocated as trigger and/or mediator of neurodegenerative diseases, such as the development of Alzheimer’s disease. Among others, Helicobacter pylori-related inflammatory mediators, defensins, autophagy, vitamin D, dietary factors, role of probiotics, and some pathogenetic considerations including relevant involved genes are discussed within this opinion article. In conclusion, by controlling the impact of Helicobacter pylori-related hyperhomocysteinemia on neurodegenerative disorders might offer benefits, and additional research is warranted to clarify this crucial topic currently representing a major worldwide burden. MDPI 2023-03-04 /pmc/articles/PMC10056452/ /pubmed/36984505 http://dx.doi.org/10.3390/medicina59030504 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Opinion Kountouras, Jannis Doulberis, Michael Papaefthymiou, Apostolis Polyzos, Stergios A. Zavos, Christos Kazakos, Evangelos Arapoglou, Stergios Kyrailidi, Foteini Mouratidou, Maria C. Boziki, Marina Vardaka, Elisabeth Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration |
title | Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration |
title_full | Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration |
title_fullStr | Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration |
title_full_unstemmed | Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration |
title_short | Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration |
title_sort | controlling the impact of helicobacter pylori-related hyperhomocysteinemia on neurodegeneration |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056452/ https://www.ncbi.nlm.nih.gov/pubmed/36984505 http://dx.doi.org/10.3390/medicina59030504 |
work_keys_str_mv | AT kountourasjannis controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT doulberismichael controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT papaefthymiouapostolis controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT polyzosstergiosa controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT zavoschristos controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT kazakosevangelos controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT arapogloustergios controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT kyrailidifoteini controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT mouratidoumariac controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT bozikimarina controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration AT vardakaelisabeth controllingtheimpactofhelicobacterpylorirelatedhyperhomocysteinemiaonneurodegeneration |